These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17542981)

  • 1. Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T-cell expansion.
    Wang SA; Yue G; Hutchinson L; Landry ML; Hasserjian RP; Hao S; Galili N; Raza A; Woda BA
    Br J Haematol; 2007 Jul; 138(2):271-5. PubMed ID: 17542981
    [No Abstract]   [Full Text] [Related]  

  • 2. Parvovirus B19-induced persistent pure red cell aplasia in a child with T-cell immunodeficiency.
    Tavil B; Sanal O; Turul T; Yel L; Gurgey A; Gumruk F
    Pediatr Hematol Oncol; 2009 Mar; 26(2):63-8. PubMed ID: 19322736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune reconstitution syndrome associated with parvovirus B19-induced pure red cell aplasia during highly active antiretroviral therapy.
    Intalapaporn P; Poovorawan Y; Suankratay C
    J Infect; 2006 Aug; 53(2):e79-82. PubMed ID: 16313965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience.
    Thompson CA; Steensma DP
    Br J Haematol; 2006 Nov; 135(3):405-7. PubMed ID: 17032177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant decrease in hemoglobin and hematocrit levels in a virologically controlled HIV-infected patient. Pure red cell aplasia (PRCA) caused by human parvovirus B19.
    Naval-Srinivas RM; Church LW
    AIDS Read; 2003 Apr; 13(4):189. PubMed ID: 12741369
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment on "Immune reconstitution syndrome associated with parvovirus B19-induced pure red cell aplasia during highly active antiretroviral therapy" by Intalapaporn et al.
    Koduri PR
    J Infect; 2007 Jul; 55(1):90-1. PubMed ID: 17083979
    [No Abstract]   [Full Text] [Related]  

  • 7. Pure red cell aplasia evolving through the hyperfibrotic myelodysplastic syndrome to the acute myeloid leukemia: some pathogenetic aspects.
    Suvajdzic N; Marisavljevic D; Jovanovic V; Pantic M; Sefer D; Colovic M
    Hematol Cell Ther; 1999 Feb; 41(1):27-9. PubMed ID: 10193643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pure red cell aplasia in patient affected by myelodysplastic syndrome treated with R-Epo].
    Luraschi A; Montanara S; Fedeli P; Buscaglia P; Fossati O; Cozzi S; Castello A
    Recenti Prog Med; 2008 May; 99(5):255-7. PubMed ID: 18581968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent pure red cell aplasia due to parvovirus B19 infection in a patient with Turner's syndrome.
    Pitchaipillai S; Kelsey P; Haeney M
    Clin Lab Haematol; 2006 Oct; 28(5):347-50. PubMed ID: 16999728
    [No Abstract]   [Full Text] [Related]  

  • 10. Pure red cell aplasia due to parvovirus B19 infection transmitted probably through hematopoietic stem cell transplantation.
    Wasak-Szulkowska E; Grabarczyk P; Rzepecki P
    Transpl Infect Dis; 2008 Jun; 10(3):201-5. PubMed ID: 17631000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathophysiology of pure red cell aplasia: implications for therapy.
    Charles RJ; Sabo KM; Kidd PG; Abkowitz JL
    Blood; 1996 Jun; 87(11):4831-8. PubMed ID: 8639856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell clonal disorder in acquired primary pure red cell aplasia.
    Bai LY; Liu JH; Kau JP
    Ann Hematol; 2004 Aug; 83(8):544-6. PubMed ID: 15141323
    [No Abstract]   [Full Text] [Related]  

  • 13. Neutropenia in parvovirus B19-associated pure red cell aplasia.
    Seo JY; Kim HJ; Kim SH
    Ann Hematol; 2011 Aug; 90(8):975-8. PubMed ID: 21052671
    [No Abstract]   [Full Text] [Related]  

  • 14. AIDS-related pure red cell aplasia.
    Majluf-Cruz A; Luna-Castańos G; Nieto-Cisneros L
    Am J Hematol; 1996 Feb; 51(2):171. PubMed ID: 8579062
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group.
    Fujishima N; Sawada K; Hirokawa M; Oshimi K; Sugimoto K; Matsuda A; Teramura M; Karasawa M; Arai A; Yonemura Y; Nakao S; Urabe A; Omine M; Ozawa K;
    Haematologica; 2008 Oct; 93(10):1555-9. PubMed ID: 18641028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myelodysplastic syndrome with erythroblastopenia].
    Martinaud C; Pons S; Ménard G; Gisserot O; de Jaureguiberry JP; Brisou P
    Rev Med Interne; 2011 Jan; 32(1):33-8. PubMed ID: 20801559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Erythroblastopenia associated with a myelodysplastic syndrome].
    Rodríguez García JA; Gil García S
    Sangre (Barc); 1996 Jun; 41(3):260. PubMed ID: 8966655
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporin successfully treats red cell aplasia associated with myelodysplasia.
    Blacklock H; Kalluru R; Nisbet M; Charman R; Royle G; Jackson S
    N Z Med J; 2003 Apr; 116(1171):U386. PubMed ID: 12740636
    [No Abstract]   [Full Text] [Related]  

  • 19. Myelodysplastic syndrome with erythroid hypoplasia: a rare and distinct clincopathological entity--a report of two cases.
    Kumar V; Dash S
    Indian J Pathol Microbiol; 2005 Jan; 48(1):36-7. PubMed ID: 16758786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes.
    Kiladjian JJ; Visentin G; Viey E; Chevret S; Eclache V; Stirnemann J; Bourhis JH; Chouaib S; Fenaux P; Caignard A
    Haematologica; 2008 Mar; 93(3):381-9. PubMed ID: 18268282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.